Clinical Trial

Effect of Food and Age on the Pharmacokinetics of LY03017

Not Yet Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated January 27, 2025 (before its estimated October 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
This study consists of 2 parts. Part A is a randomized, open-label, 2-period, crossover study to evaluate the food effect of LY03017 in healthy adults. Part B is a single-arm study to evaluate the safety and pharmacokinetics of LY03017 in elderly volunteers.
Trial Details
NCT Number NCT06793995
Lead Sponsor Luye Pharma Group Ltd.
Conditions Alzheimer's Disease Psychosis, Parkinson Disease Psychosis, Negative Symptoms of Schizophrenia
Enrollment 26 participants
Start Date 2025-02
Primary Completion 2025-10-31 (estimated)
Study Completion 2025-10-31 (estimated)
Updated on ClinicalTrials.gov 2025-01-27